In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro

Blood

Volumn 92, Issue 11, 1998, Pages 4366-4374

  Leavey, Patrick J ^a   Sellins, Karen S ^a   Thurman, Gail ^a   Elzi, David ^a   Hiester, Andrew ^a   Silliman, Christopher C ^a   Zerbe, Gary ^a   Cohen, J John ^a   Ambruso, Daniel R ^a,b  

^a Univ of Colorado School of Medicine ^*  (United States)

^b Bonfils Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; F ACTIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; OXIDOREDUCTASE; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; THROMBOCYTE ACTIVATING FACTOR; ZYMOSAN;

ARTICLE; CALCIUM MOBILIZATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE FUNCTION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032400874     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4366.423k23_4366_4374     Document Type: Article

References (59)

1. Elsner J, Roesler J, Emmendorffer A, Lohmann-Matthes ML, Welte K: Abnormal regulation in the signal transduction in neutrophils from patients with severe congenital neutropenia: Relation of impaired mobilization of cytosolic free calcium to altered chemotaxis, superoxide anion generation and F-actin content. Exp Hematol 21:38, 1993
2. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, Mertelsmann R: Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74:2644, 1989
3. Kaposzta R, Marodi L: Chronic neutropenia and defect in superoxide generation of granulocytes in two patients: Enhancement of bactericidal capacity and respiratory burst activity by treatment with recombinant human granulocyte colony-stimulating factor. Pediatr Res 37:50, 1995
4. Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL: Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 110:976, 1989
5. Nicola NA: Granulocyte colony stimulating factor, in Dexter TM, Garland JM, Testa NG (eds): Colony-Stimulating Factors. New York, NY, Dekker, 1990, p 77
6. Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K: Functional features of neutrophils induced by G-CSF and GM-CSF treatment; Differential effects and clinical implications. Leukemia 11:466, 1997
7. Liles WC, Klebanoff SJ: Regulation of apoptosis in neutrophils - Fas track to death? J Immunol 155:3289, 1995
8. Wang JM, Chen ZG, Colella S, Bonilla MA, Welte K, Bordignon C, Mantovani A: Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 72:1456, 1988
9. Sullivan GW, Carper HT, Mandell GL: The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 81:1863, 1993
10. Sato N, Asano S, Koeffler HP, Yoshida S, Takaku F, Takatani O: Identification of neutrophil alkaline phosphatase-inducing factor in cystic fluid of a human squamous cell carcinoma as granulocyte colony-stimulating factor. J Cell Physiol 137:272, 1988
11. Sato N, Mizukami H, Tani K, Asano S: Regulation of mRNA levels of alkaline phosphatase gene in neutrophilic granulocytes by granulocyte colony-stimulating factor and retinoic acid. Eur J Haematol 46:107, 1991
12. Gottlieb RA, Giesing HA, Zhu JY, Engler RL, Babior BM: Cell acidification in apoptosis: Granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase. Proc Natl Acad Sci USA 92:5965, 1995
13. Squier MK, Sehnert AJ, Cohen JJ: Apoptosis in leukocytes, J Leukoc Biol 57:2, 1995
14. Price TH, Chatta GS, Dale DC: Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88:335, 1996
15. de Haas M, Kerst JM, van der School CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE: Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils. Blood 84:3885, 1994
16. Kerst JM, van de Winkel JG, Evans AH, de Haas M, Slaper-Cortenbach IC, de Wit TP, von dem Borne AE, van der School CE, van Oers RH: Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood 81:1457, 1993
17. Fossat C, Stoppa AM, Sainty D, Blaise D, Viens P, Juhan-Vague I, Maraninchi D, Carcassonne Y: G-CSF in vivo improves neutrophils bactericidal activity against pseudomonas aeruginosae in cancer patients. Blood 76:144a, 1990 (abstr)
18. Liles WC, Huang JE, van Burik JH, Bowden RA, Dale DC: Granulocyte colony stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis 175:1012, 1997
19. Kerst JM, de Haas M, van der School CE, Slaper-Cortenbach IC, Kleijer M, von dem Borne AE, van Oers RH: Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82:3265, 1993
20. Ambruso DR, Brentwood B, Henson PM, Johnston RB Jr: Oxidative metabolism of cord blood neutrophils: Relationship to content and degranulation of cytoplasmic granules. Pediatr Res 18: 1148, 1984
21. Maderazo EG, Ward PA: Leukocyte chemotaxis, in Rose NR, Friedman NH, Fahey JL (eds): Manual of Clinical Immunology. Washington, DC, American Society for Microbiology, 1986, p 290
22. Harbeck RJ, Giclas PC: Assessment of neutrophil functioning and general methods for neutrophil isolation, in Diagnostic Immunology Laboratory Maunal. New York, NY, Raven, 1991, p 223
23. Howard TH, Meyer WH: Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol 98:1265, 1984
24. Lazzari KG, Proto PJ, Simons ER: Simultaneous measurement of stimulus-induced changes in cytoplasmic Ca2+ and in membrane potential of human neutrophils. J Biol Chem 261:9710, 1986
25. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440, 1985
26. Ambruso DR, Sasada M, Nishiyama H, Kubo A, Komiyama A, Allen RH: Defective bactericidal activity and absence of specific granules in neutrophils from a patient with recurrent bacterial infections. J Clin Immunol 4:23, 1984
27. Johnston RB III, Harbeck RJ, Johnston RB Jr: Recurrent severe infections in a girl with apparently variable expression of mosaicism for chronic granulomatous disease. J Pediatr 106:50, 1985
28. Rosenthal J, Thurman GW, Cusack N, Peterson VM, Malech HL, Ambruso DR: Neutrophils from patients after burn injury express a deficiency of the oxidase components p47-phox and p67-phox. Blood 88:4321, 1996
29. Ambruso DR, Stork LC, Gibson BE, Thurman GW: Increased activity of the respiratory burst in cord blood neutrophils: Kinetics of the NADPH oxidase enzyme system in subcellular fractions. Pediatr Res 21:205, 1987
30. 2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J Biol Chem 265:924, 1990
31. Brentwood BJ, Henson PM: The sequential release of granule constituents from human neutrophils. J Immunol 124:855, 1980
32. Peterson VM, Ambruso DR, Emmett M, Bartle EJ: Inhibition of colony-stimulating factor (CSF) production by postburn serum: Negative feedback inhibition mediated by lactoferrin. J Trauma 28:1533, 1988
33. Duke RC, Cohen JJ, Boehme SA, Lenardo MJ, Surh CD, Kishimoto H, Sprent J: Morphological, biochemical and flow cytometric assays of apoptosis, in Coligan JE, Kruisbeek AM, Margulies DH, Sevach EM, Strober W (eds): Current Protocols in Immunology. New York, NY, Wiley, 1995, p 3.17.1
34. Cole JW, Grizzle JE: Applications of multivariate analysis of variance to repeated measurements experiments. Biometrics 22:810, 1966
35. Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, Urabe A, Saito M, Takaku F: Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74:2144, 1989
36. Ohsaka A, Kitagawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F, Saito M: In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 74:2743, 1989
37. Ohsaka A, Kitagawa S, Yuo A, Motoyoshi K, Ohta M, Miura Y, Takaku F, Saito M: Increased respiratory burst activity of neutrophils in patients with aplastic anemia: Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Exp Hematol 20:1090, 1992
38. Glaspy JA, Bleecker G, Crawford J, Stoller R, Strauss M: The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy. Eur J Cancer 29A7:S23, 1993 (suppl 7)
39. Linch DC, Scarffe H, Proctor S, Chopra R, Taylor PR, Morgenstern G, Cunningham D, Burnett AK, Cawley JC, Franklin IM: Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant 11:307, 1993
40. Schroten H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes M, Wahn V, Welte K: Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr 119:748, 1991
41. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907, 1996
42. Dale DC, Liles WC, Summer WR, Nelson S: Review: Granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis 172:1061, 1995
43. Balazovich KJ, Almeida HI, Boxer LA: Recombinant human G-CSF and GM-CSF prime human neutrophils for Superoxide production through different signal transduction mechanisms. J Lab Clin Med 118:576, 1991
44. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012, 1992
45. Liles WC, Rodger ER, Dale DC: Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18 and L-selectin following the administration of G-CSF in vivo and in vitro. Clin Res 42:304a, 1994 (abstr)
46. Hilmo A, Howard TH: F-actin content of neonate and adult neutrophils. Blood 69:945, 1987
47. McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L: In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: Granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. Pediatr Res 35:84, 1994
48. Ambruso DR, Thurman GW, Cusack NA, Occena R, Sokol RJ: G-CSF treatment of a patient with glycogen storage disease (GSD) Ib resolved ulcerative colitis but had no efect on functional capacity of neutrophils (PMNs). Clin Res 42:186a, 1994 (abstr)
49. Ambruso DR, Peterson VP: Phagocyte function, in Phagocyte Production and Function Following Burn Injury. Austin, TX, Landes, 1994, p 60
50. West BC, Rosenthal AS, Gelb NA, Kimball HR: Separation and characterization of human neutrophil granules. Am J Pathol 77:41, 1974
51. Borregaard N, Cowland JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503, 1997
52. Macey MG, Sangster J, Kelsey SM, Newland AC: Pilot study: Effects of G-CSF on neutrophil ex-vivo function post bone marrow transplantation. Clin Lab Haematol 15:79, 1993
53. Khwaja A, Carver JE, Linch DC: Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst. Blood 79:745, 1992
54. Shearman MS, Hey worth CM, Dexter TM, Haefner B, Owen PJ, Whetton AD: Haemopoietic stem cell development to neutrophils is associated with subcellular redistribution and differential expression of protein kinase C subspecies. J Cell Sci 104:173, 1993
55. Teshima T, Shibuya T, Harada M, Akashi K, Taniguchi S, Okamura T, Niho Y: Granulocyte-macrophage colony-stimulating factor suppresses induction of neutrophil alkaline phosphatase synthesis by granulocyte colony-stimulating factor. Exp Hematol 18:316, 1990
56. Weston B, Todd RF III, Axtell R, Balazovich K, Stewart J, Locey BJ, Mayo-Bond L, Loos P, Hutchinson R, Boxer LA: Severe congenital neutropenia: Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. J Lab Clin Med 117:282, 1991
57. Adachi S, Kubota M, Lin YW, Okuda A, Matsubara K, Wakazono Y, Hirota H, Kuwakado K, Akiyama Y: In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro. Eur J Haematol 53:129, 1994
58. Lagasse E, Weissman IL: bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 179:1047, 1994
59. Leavey PJ, Sellins KS, Cohen JJ, Ambruso DR: Granulocyte colony stimulating factor (filgrastim) administration to normal volunteers prolongs the survival of isolated neutrophils. J Invest Med 44:231A, 1996 (abstr)